Vaso-occlusive Crisis Clinical Trials
2 recruiting trials for Vaso-occlusive Crisis. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Vaso-occlusive Crisis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by St. Jude Children's Research Hospital (1), BILLOIR (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Virtual Reality Therapy (other, 1 trial), followed by Erythrocytic parameters and thrombin generation assay measurement.
Track Vaso-occlusive Crisis trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Acute vaso-occlusive crisis (VOC) is the most common complication in patients with sickle cell disease (SCD) and pain related to VOC is often inadequately treated. This is a phase...
Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA)
Sickle cell disease (SCD) is an inherited haemoglobinopathy disorder caused by mutations in HBB gene with amino-acid substitution on β globin chain. The consequence is synthesis...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Vaso-occlusive Crisis, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Vaso-occlusive Crisis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Vaso-occlusive Crisis, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.